Nkarta (NKTX) Interest & Investment Income (2019 - 2026)

Nkarta's (NKTX) quarterly Interest & Investment Income came in at $2.8 million in Q1 2026, down 35.15% year-on-year from $4.4 million in Q1 2025, and down 13.9% quarter-over-quarter from $3.3 million in Q4 2025.

Nkarta (NKTX) Interest & Investment Income (2019 - 2026) Analysis & Trends

Nkarta's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $2.8 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 35.15% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a 31.75% decrease from a year earlier, with the FY2025 full-year figure at $15.5 million, down 19.79% from the prior year.
  • Interest & Investment Income fell to $2.8 million in Q1 2026 per NKTX's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $5.7 million in Q2 2024 and bottomed at $112000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $3.5 million (2023), against an average of $3.4 million.
  • Across the five-year window, Interest & Investment Income surged 2993.75% in 2023 and tumbled 35.15% in 2026, its largest moves.
  • Year by year, Interest & Investment Income stood at $2.9 million in 2022, then rose by 19.58% to $3.5 million in 2023, then soared by 41.61% to $4.9 million in 2024, then tumbled by 32.65% to $3.3 million in 2025, then slipped by 13.9% to $2.8 million in 2026.
  • Per Business Quant, the three latest NKTX Interest & Investment Income figures stand at $2.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Nkarta 168.94 Mn 168.94 Mn - 2.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.84 Mn
Dec 31, 2025 3.30 Mn
Sep 30, 2025 3.85 Mn
Jun 30, 2025 3.97 Mn
Mar 31, 2025 4.38 Mn
Dec 31, 2024 4.89 Mn
Sep 30, 2024 5.45 Mn
Jun 30, 2024 5.72 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 3.46 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 3.57 Mn
Mar 31, 2023 3.47 Mn
Dec 31, 2022 2.89 Mn
Sep 30, 2022 1.90 Mn
Jun 30, 2022 686,000.00
Mar 31, 2022 112,000.00
Dec 31, 2021 -448,000.00
Sep 30, 2021 81,000.00
Jun 30, 2021 104,000.00